NatureCell Statistics
Total Valuation
NatureCell has a market cap or net worth of KRW 2.08 trillion. The enterprise value is 2.07 trillion.
| Market Cap | 2.08T |
| Enterprise Value | 2.07T |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NatureCell has 64.44 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Current Share Class | 64.44M |
| Shares Outstanding | 64.44M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 2.07% |
| Owned by Institutions (%) | 5.31% |
| Float | 52.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 100.46 |
| PB Ratio | 32.99 |
| P/TBV Ratio | 34.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 2,155.57 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -756.23 |
| EV / Sales | 100.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -146.30 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.94 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.38 |
| Interest Coverage | -9.98 |
Financial Efficiency
Return on equity (ROE) is -4.33% and return on invested capital (ROIC) is -6.02%.
| Return on Equity (ROE) | -4.33% |
| Return on Assets (ROA) | -2.59% |
| Return on Invested Capital (ROIC) | -6.02% |
| Return on Capital Employed (ROCE) | -4.96% |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | 269.05M |
| Profits Per Employee | -35.59M |
| Employee Count | 87 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, NatureCell has paid 71.61 million in taxes.
| Income Tax | 71.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.18% in the last 52 weeks. The beta is 0.37, so NatureCell's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +28.18% |
| 50-Day Moving Average | 19,638.60 |
| 200-Day Moving Average | 21,891.00 |
| Relative Strength Index (RSI) | 80.55 |
| Average Volume (20 Days) | 654,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NatureCell had revenue of KRW 20.72 billion and -2.74 billion in losses. Loss per share was -42.54.
| Revenue | 20.72B |
| Gross Profit | 10.06B |
| Operating Income | -3.26B |
| Pretax Income | -2.67B |
| Net Income | -2.74B |
| EBITDA | -1.41B |
| EBIT | -3.26B |
| Loss Per Share | -42.54 |
Balance Sheet
The company has 28.34 billion in cash and 19.61 billion in debt, with a net cash position of 8.73 billion or 135.53 per share.
| Cash & Cash Equivalents | 28.34B |
| Total Debt | 19.61B |
| Net Cash | 8.73B |
| Net Cash Per Share | 135.53 |
| Equity (Book Value) | 63.09B |
| Book Value Per Share | 979.17 |
| Working Capital | 19.65B |
Cash Flow
In the last 12 months, operating cash flow was 965.52 million and capital expenditures -15.13 billion, giving a free cash flow of -14.17 billion.
| Operating Cash Flow | 965.52M |
| Capital Expenditures | -15.13B |
| Depreciation & Amortization | 1.85B |
| Net Borrowing | 16.02B |
| Free Cash Flow | -14.17B |
| FCF Per Share | -219.85 |
Margins
Gross margin is 48.57%, with operating and profit margins of -15.75% and -13.23%.
| Gross Margin | 48.57% |
| Operating Margin | -15.75% |
| Pretax Margin | -12.88% |
| Profit Margin | -13.23% |
| EBITDA Margin | -6.81% |
| EBIT Margin | -15.75% |
| FCF Margin | n/a |
Dividends & Yields
NatureCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
| Earnings Yield | -0.13% |
| FCF Yield | -0.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NatureCell has an Altman Z-Score of 38.54 and a Piotroski F-Score of 3.
| Altman Z-Score | 38.54 |
| Piotroski F-Score | 3 |